Neoadjuvant Therapy in Breast Cancer: A New Raison D’être
In the past 50 years, use of neoadjuvant chemotherapy for breast cancer has evolved. Today, clinicians at NewYork-Presbyterian are using neoadjuvant therapy to tackle residual tumor.
Oncology
Targeting Early Breast Cancers with Ablation Therapies
Surgeons at NewYork-Presbyterian/Columbia are turning up the heat (or cold as the case may be) on early-stage breast cancer tumors with the use of ablation therapies.
Oncology
Immunotherapy: A New Frontier in Genitourinary Cancers
Charles G. Drake was presented with a unique opportunity to build a genitourinary cancer group with the focus on trying to cure these cancers with the immune system.
Oncology
Ovarian Cancer: Overcoming Obstacles to Immunotherapy
The promise of immunotherapy is altering how many cancers are perceived and treated, but it has so far eluded the treatment for some of the more aggressive malignancies, including ovarian cancer.